Correction: Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Advancing Beyond Inhibition: Utilizing the DRD2–VEGF-A Feedback Mechanism for Targeted Anti-Angiogenesis Treatment in Oncology

  • By

  • Manas Ranjan Sahu

  • Venu Akkanapally

  • Partha Sarathi Dasgupta

  • Sujit Basu

  • September 2, 2026

Share

  • 1

    The article discusses a correction regarding funding information in a previous publication on anti-angiogenesis therapy.

  • 2

    Incorrect NIH/NCI and DOD USA grant information was identified in the original article's funding statement.

  • 3

    The corrected funding statement attributes financial support to the Ohio State University Comprehensive Cancer Center.

  • 4

    The correction affects the authors MR Sahu, V Akkanapally, and S Basu.

  • 5

    The original article has been updated to reflect the accurate funding information.

Original Source(s)

Correction: Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

  • by Manas Ranjan Sahu, Venu Akkanapally, Partha Sarathi Dasgupta, Sujit Basu

  • September 2, 2026

Related Content

Correction: Primary cutaneous adenoid cystic carcinoma of the right forearm: a case report and dermoscopic features

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms

Toward Precision Cardio-Oncology in Breast Radiotherapy